Globus Medical Stock Performance
| GMED Stock | USD 73.59 0.32 0.43% |
The company retains a Market Volatility (i.e., Beta) of 0.9, which attests to possible diversification benefits within a given portfolio. Globus Medical returns are very sensitive to returns on the market. As the market goes up or down, Globus Medical is expected to follow. At this point, Globus Medical has a negative expected return of -0.19%. Please make sure to check out Globus Medical's kurtosis, and the relationship between the value at risk and rate of daily change , to decide if Globus Medical performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Over the last 90 days Globus Medical has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's technical and fundamental indicators remain sound and the latest tumult on Wall Street may also be a sign of longer-term gains for the firm shareholders. ...more
Actual Historical Performance (%)
One Day Return (0.43) | Five Day Return 4.9 | Year To Date Return (10.07) | Ten Year Return 204.59 | All Time Return 445.11 |
1 | Acquisition by Daniel Scavilla of 30000 shares of Globus Medical at 26.27 subject to Rule 16b-3 | 12/20/2024 |
2 | Acquisition by Keith Pfeil of 5833 shares of Globus Medical at 49.65 subject to Rule 16b-3 | 01/14/2025 |
3 | Globus Medical to Acquire Nevro Corp.to Expand Treatment Options for Patients | 02/06/2025 |
4 | OPEX stellt Lagerautomatisierungslsungen der nchsten Generation auf LogiMAT Deutschland vor, Europas grter Fachmesse fr Lager- und Intra-Logistik | 02/25/2025 |
5 | There May Be Reason For Hope In Globus Medicals Disappointing Earnings | 03/05/2025 |
6 | Globus Medical Inc to Present at Canaccord Genuity 2025 Musculoskeletal Conference | 03/06/2025 |
7 | OsteoCentric Technologies Enters into a Non-Exclusive Licensing Agreement with Globus Medical | 03/11/2025 |
8 | Globus Medical Inc Trading Down 3.14 percent on Mar 12 | 03/12/2025 |
9 | Globus Maritime Announces Filing of its 2024 Annual Report on Form 20--F | 03/14/2025 |
10 | Truist Cuts Price Target on Globus Medical to 82 From 90, Keeps Hold Rating -March 18, 2025 at 0708 am EDT - Marketscreener.com | 03/18/2025 |
11 | Globus Medical shareholders notch a 11 percent CAGR over 5 years, yet earnings have been shrinking | 03/20/2025 |
| Begin Period Cash Flow | 467.3 M |
Globus |
Globus Medical Relative Risk vs. Return Landscape
If you would invest 8,310 in Globus Medical on December 22, 2024 and sell it today you would lose (951.00) from holding Globus Medical or give up 11.44% of portfolio value over 90 days. Globus Medical is currently does not generate positive expected returns and assumes 1.6586% risk (volatility on return distribution) over the 90 days horizon. In different words, 14% of stocks are less volatile than Globus, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Globus Medical Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Globus Medical's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Globus Medical, and traders can use it to determine the average amount a Globus Medical's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.1138
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | GMED |
Estimated Market Risk
| 1.66 actual daily | 14 86% of assets are more volatile |
Expected Return
| -0.19 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.11 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Globus Medical is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Globus Medical by adding Globus Medical to a well-diversified portfolio.
Globus Medical Fundamentals Growth
Globus Stock prices reflect investors' perceptions of the future prospects and financial health of Globus Medical, and Globus Medical fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Globus Stock performance.
| Return On Equity | 0.0252 | ||||
| Return On Asset | 0.0533 | ||||
| Profit Margin | 0.04 % | ||||
| Operating Margin | 0.19 % | ||||
| Current Valuation | 9.73 B | ||||
| Shares Outstanding | 115.11 M | ||||
| Price To Earning | 73.16 X | ||||
| Price To Book | 2.41 X | ||||
| Price To Sales | 4.04 X | ||||
| Revenue | 2.52 B | ||||
| Gross Profit | 1.7 B | ||||
| EBITDA | 473.73 M | ||||
| Net Income | 102.98 M | ||||
| Cash And Equivalents | 408.01 M | ||||
| Cash Per Share | 4.10 X | ||||
| Total Debt | 537.19 M | ||||
| Debt To Equity | 0 % | ||||
| Current Ratio | 6.10 X | ||||
| Book Value Per Share | 30.40 X | ||||
| Cash Flow From Operations | 520.64 M | ||||
| Earnings Per Share | 0.75 X | ||||
| Market Capitalization | 10.17 B | ||||
| Total Asset | 5.25 B | ||||
| Retained Earnings | 1.15 B | ||||
| Working Capital | 1.32 B | ||||
| Current Asset | 544.8 M | ||||
| Current Liabilities | 82.69 M | ||||
About Globus Medical Performance
By analyzing Globus Medical's fundamental ratios, stakeholders can gain valuable insights into Globus Medical's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Globus Medical has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Globus Medical has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 232.38 | 261.32 | |
| Return On Tangible Assets | 0.03 | 0.03 | |
| Return On Capital Employed | 0.04 | 0.04 | |
| Return On Assets | 0.02 | 0.02 | |
| Return On Equity | 0.02 | 0.02 |
Things to note about Globus Medical performance evaluation
Checking the ongoing alerts about Globus Medical for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Globus Medical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Globus Medical generated a negative expected return over the last 90 days | |
| Over 82.0% of the company shares are owned by institutional investors | |
| Latest headline from simplywall.st: Globus Medical shareholders notch a 11 percent CAGR over 5 years, yet earnings have been shrinking |
- Analyzing Globus Medical's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Globus Medical's stock is overvalued or undervalued compared to its peers.
- Examining Globus Medical's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Globus Medical's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Globus Medical's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Globus Medical's stock. These opinions can provide insight into Globus Medical's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Globus Stock analysis
When running Globus Medical's price analysis, check to measure Globus Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Globus Medical is operating at the current time. Most of Globus Medical's value examination focuses on studying past and present price action to predict the probability of Globus Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Globus Medical's price. Additionally, you may evaluate how the addition of Globus Medical to your portfolios can decrease your overall portfolio volatility.
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal |